The stigma associated with cutaneous leishmaniasis (CL) and mucocutaneous leishmaniasis (MCL): A protocol for a systematic review. [PDF]
Nuwangi H +5 more
europepmc +1 more source
Evaluation of dot enzyme-linked immunosorbent assay for mucocutaneous leishmaniasis and comparison with microplate enzyme immunoassay [PDF]
Maria Carolina Soares Guimarães +2 more
openalex +1 more source
INTRODUCTION American tegumentary leishmaniasis (ATL) is an endemic disease in many regions of Brazil; however, only few reports on the actual epidemiological conditions are available.
Priscila Wolf Nassif +7 more
doaj +1 more source
A Potential New Source of Therapeutic Agents for the Treatment of Mucocutaneous Leishmaniasis: The Essential Oil of Rhaphiodon echinus. [PDF]
Oliveira CVB +14 more
europepmc +1 more source
Clinicopathological characteristics of cutaneous and mucocutaneous leishmaniasis in patients treated with TNF‐α inhibitors [PDF]
Rodolfo David Palacios‐Diaz +12 more
openalex +1 more source
Leishmaniasis: A review of the disease and the debate over the origin and dispersal of the causaitive parasite Leishmania [PDF]
The vector borne disease Leishmaniasis, caused by the Leishmania parasite, is estimated to affect the lives of 12 million people. Manifesting itself into three different clinical forms that center on disfiguring sores and enlargement of several organs ...
MacMorris-Adix, Molly
core +1 more source
Cutaneous and Mucocutaneous Leishmaniasis: Perspectives on Immunity, Virulence, and Treatment [PDF]
Felipe Francisco Tuon +5 more
openalex +1 more source
Identification and purification of a 72kDa antigen of Leishmania braziliensis braziliensis present on the surface and in the cytoplasm of the promastigotes and its specific recognition by sera from mucocutaneous leishmaniasis patients [PDF]
Shirley Kutner +4 more
openalex +1 more source
A Review of the Progress in the Development of Leishmaniasis Vaccines [PDF]
Leishmaniasis is a parasitic infectious disease that accounts for approximately one million new cases annually. The treatment of this disease is complex and costly, particularly in developing countries.
Narges Khaghanzadeh +2 more
doaj
American Tegumentary Leishmaniasis: Is Antimonial Treatment Outcome Related to Parasite Drug Susceptibility? [PDF]
BackgroundAntimonials are the first drug of choice for the treatment of American tegumentary leishmaniasis (ATL); however, their efficacy is not predictable, and this may be linked to parasite drug resistance.
Adui, Vanessa +11 more
core

